Two hundred and five patients who received a total of 247 electrode systems-129 transvenous, 68 transmediastinal and 50 transthoracic-are compared after complete uniform two-year followup. The transvenous patients had low hospital morbidity (19%) and short hospital stays (75% < 8 days) but a high incidence of electrode failure by 24 months (38%). The transmediastinal and transthoracic patients had more hospital complications (35% and 34%) and longer periods of hospitalization (57% and 70% > 8 days) but fewer instances of failure by 24 months (16% and 11%). Most transvenous electrode failures were secondary to dislodgement. Transmediastinal right epicardial electrodes had the unique problem of threshold elevation and failure between six and 12 months after implantation as well as a high incidence of sudden death in this same period. Although the high incidence of endocardial elec rode instability dictates the need for an alternative approach to permanent pacing, the failure of the transmediastinal approach to significantly alter postoperative morbidity (as compared with transthoracic electrodes) and the incidence of threshold elevation remote from right ventricular implantation suggest that limitation of thoracotomy (via the transmediastinal approach) should not take precedence over left ventricular implantation. Development of electrodes which would provide more permanent low resistance fixation to right ventricular endocardium or epicardium may be necessary before the transthoracic approach can be abandoned.
acing
Endocardial pacing
Methods
This study includes the entire pacing experience with bipolar ventricular electrode systems in 205 consecutive patients who received an original or replacement Medtronic pulse generator at Duke Hospital between January 1, 1967 and December 31, 1970 . This included 414 pulse generators of several different model types, including fixed rate models 5860C, 5862, 5864, 5868, 5870 and 5870C, and demand models 5841 and 5842. There were 247 electrode systems of which 129 were transvenous, 68 transmediastinal and 50 transthoracic. Two-year followup was 99.6% complete.
Rigid criteria were established for etiology of underlying heart disease, major associated illnesses, hospital complications, electrode failure and death. Charts were retrospectively reviewed and data extracted and then stored in a Sigma V (Xerox Data Systems) computer for subsequent analysis. Statistical significance was determined by chi square or t-test.
Coronary artery disease was defined by either QRS changes on ECG or cardiac enzyme elevation indicative of myocardial infarction or a history of classic angina pectoris. Idiopathic heart disease was a diagnosis of exclusion. Congestive heart failure was defined by the r'resence of any two of the following findings: rales, S3 gallop or chest X-ray changes. Hypertension was defined by the presence of at least two blood pressure recordings of greater than 140/90 mm Hg. Diabetes mellitus was deemed present if the fasting blood sugar was >110 mg %, two-hour postprandial sugar >120, or if a glucose tolerance test was abnormal (FBS > 110, 1 hour > 160, 2 hours > 120).
Hospital complications were considered significant only if they resulted in unplanned intervention by the physician. Cardiac complications consisted of dysrhythmia (ventricular tachycardia or ventricular fibrillation requiring therapy), percardial tamponade (pericardial effusion or mediastinal hematoma resulting in hemodynamic compromise), myocardial infarction (QRS change and/or cardiac enzyme elevation) and congestive heart failure. Pleural effusion was quite common following thoracotomy. It was considered to be a complication only if a chest tube remained in place more than 24 hours following surgery, if insertion was required during the recovery period, if there was bleeding into the pleural space requiring transfusion, or if a thoracentesis was performed. Atelectasis, also very common after thoracotomy, was included only if it became necessary to invoke repeated nasotracheal suction. Pneumothorax and empyema were included if a chest tube was left in place longer than 24 hours or reinserted. Pneumonia was included only if fever, purulent sputum and a radiographic infiltrate were present. Hematologic complications consisted of hemorrhage and anemia, and were deemed significant only if a blood transfusion was required. Thromboembolic complications consisted of both venous and arterial thromboembolism resulting in anticoagulation, anti-inflammatory agents or surgical intervention. Local wound complications, both hematomas and infection, could not be rigidly defined by retrospective analysis.
We defined "electrode complication" as an event requiring surgical intervention but not replacement of the electrode.`Electrode failure" includes these and also electrode problems which resulted in replacement of the lead system. Death was coded as sudden or not sudden and explained or unexplained. In this report, "<sudden death" is used only when the event was both sudden and unexplained, thus excluding those deaths (though sudden) that occurred as the end result of a known, gradually deteriorating clinical situation-e.g., refractory congestive heart failure.
The' transvenous electrodes were introduced via the cephalic or external jugular vein to the apex of the right ventricle under image intensification fluoroscopy. Electrode position was accepted only when the tip was pointed downward and the bipolar pacing threshold was less than 1.5 ma (Medtronic #5880 portable pulse generator). Voltage thresholds were not recorded and therefore resistances were not calculated. Catheter position was adjusted to avoid redundancy which might produce undue flexion at the tricuspid valve. Position on fluoroscopy and pacing threshold were rechecked after a series of respiratory, neck and arm movements by the patient. Absolute bedrest was maintained for 48 hours. Re-evaluation of electrode position by standinr P.A. and lateral X-rays was performed prior to hospital discharge. Electrode placement was performed by cardiovascular trainees under the direction of senior staff cardiologists. The transthoracic approach, the epicardial method prior to 1968, was performed via a standard left anterolateral thoracotomy"l under general anesthesia. Electrocardiogram confirmed left ventricular pacing site in all patients except one. Chest tubes were routinely placed for a 12-to 24-hour period. The transmediastinal approach, the epicardial method of choice after 1968, was performed as previously described.2 Under general anesthesia, the pericardium was entered via a left parasternal incision after removal of the fifth left costal cartilage. The epicardial electrodes were sutured to the portion of the heart presenting through this incision, usually the right ventricle (as subsequently determined by ECG). Frequently, the left pleural space was inadvertently entered and occasionally chest tubes were placed for a 12-to 24-hour period.
Results

Patient Characteristics at the Time of Initial Implant
The three electrode groups-transvenous, transmediastinal and transthoracic-were compared in regard to age, history of syncope, presence of congestive heart failure, presence of coronary artery disease, and concurrent diseases.
The transvenous patients were older (mean age 70.3) (P < 0.05) and transthoracic patients younger (mean age 64.0) than the transmediastinal patients (mean age 66.0) and than the group as a whole (mean age 66.8) (table 1). The majority (68%) of patients had a history of syncope.
About one-third of the transvenous and transmediastinal patients had congestive heart failure preceding pacemaker implantation, but only 19% of the transthoracic patients had preceding congestive heart failure.
Most patients in all groups had heart disease of indefinable cause as the basis for permanent pacing (idiopathic). The transvenous patients had the highest incidence of coronary artery disease (34%) (definite ECG or cardiac enzyme evidence of myo- cardial infarction or a history of classic angina pectoris), while the transmediastinal group (17%) and the transthoracic patients (6%) had a lower incidence (table 2) .
Major associated illnesses also differed among the three electrode systems, with the transvenous group having the highest incidence of associated major illnesses (49% had hypertension, 31% diabetes), the transmediastinal group intermediate (39% hypertension, 26% diabetes), and the transthoracic the lowest (22% hypertension, 19% diabetes) (table 3) .
Differences were statistically significant only between transvenous and transthoracic groups when compared regarding the presence of coronary artery disease and hypertension (P < .01).
Hospital Complications of Electrode Insertion
Complications between the time of insertion and hospital discharge occurred in 19% of transvenous patients, 35% of transmediastinal patients, and 34% of transthoracic patients. These are listed in table 4. Some patients had more than one type of complication.
In the transvenous group, local wound complications were most frequent (9%). Six patients had cardiac complications: three had dysrhythmias, pericardial tamponade occurred in two, and one other had acute myocardial infarction. Two pulmonary complications were noted-pleural effusion and pneumonia-each occurring in one patient. Two patients had significant hemorrhage and four developed anemia. One patient had a venous and another an arterial thromboembolic complication.
In the transmediastinal group, pulmonary complications predominated. They included five patients with pneumonia, two with pneumothorax, and seven instances of significant pleural effusions or atelectasis. One local wound complication (infection) was noted. The four cardiac complications included one patient with postoperative myocardial infarction and three who experienced episodes of congestive heart failure. In addition, two transmediastinal patients had anemia, one had a venous thromboembolic complication, and three had arterial thromboembolic complications.
In the transthoracic group, pulmonary complications also predominated. The 10 instances included one patient with pneumonia, one with pneumothorax, one with an empyema and seven instances of significant pleural effusion or atelectasis. Two wound complications, both infections, were noted. Cardiac complications were seen in seven patients; four experienced dysrhythmia, two developed acute myocardial infarction and one had cardiac tamponade. One patient had significant hemorrhage and one a venous thromboembolic complication.
The number of days from pacemaker insertion to hospital discharge as a reflection of hospital morbidity is defined in table 5. Prolonged periods of hospitalization following insertion, greater than eight days, predominated in the epicardial systems, with 57% transmediastinal and 70% transthoracic patients staying longer than eight days, while 75% transvenous patients were discharged by eight days.
Twelve percent transthoracic patients stayed longer than three weeks, compared with 6% transmediastinal and 2% transvenous. Incidence of both pulmonary complications and prolonged periods of hospitalization was much higher (P<.01) in epicardial than in endocardial implantations. There was no significant difference in these parameters between the two epicardial methods.
Electrode Replacement (table 6) Twenty-two percent of the transvenous electrodes required replacement by 24 months. Most of these (17 out of 28) were caused by dislodgement and perforation, eight were due to infection or erosion and three were secondary to threshold elevator without demonstrable wire break. The 17 instances of electrode displacement tended to occur early (14 by six months) and were not related to preceding congestive heart failure. The complications of infection and erosion tended to be evenly distributed over the two-year period-two between hospital discharge and six months, one between 12 and 18 months, and three between 18 and 24 months. The three incidences of threshold elevation (greater than 7 ma) occurred in the interval from hospital discharge to six months.
In contrast, 7% of transmediastinal and 2% transthoracic electrodes were replaced by 24 months. Three of the five transmediastinal replacements oc- Sixteen percent of the transvenous electrode patients had hospital admissions for complications by 24 months that were successfully managed without resorting to implantation of a new electrode system. Most (14 of 21) required repositioning because of dislodgement or perforation, and most of these (12 of 14) occurred by six months. Other transvenous complications included four instances of erosion and/or infection, and five instances of failure to pace due to either threshold rise or single lead fracture that were handled by conversion from a bipolar to a unipolar pacing system.
Nine percent of patients with transmediastinal and 10% with transthoracic implantations had electrode complications which required hospitalization for correction by 24 months. Five of the six with transmediastinal and four of the five with transthoracic electrode complications were successfully converted from a bipolar to a unipolar system. Four of the five patients with transmediastinal electrodes thus converted had unipolar threshold elevations (greater than 7 ma) without demonstrable wire break, while four of four with transthoracic electrodes thus converted had demonstrable wire break. Of interest was the fact that, although threshold elevation accounted for only 6% (3/49) of all instances of transvenous electrode failure (those requiring replacement or revision) and for no transthoracic failures, it accounted for 64% (7/11) of the instances of transmediastinal electrode failure. Furthermore, six of these latter seven occurred in the interval between six and 12 months after insertion, and all six had right epicardial leads as determined by ECG. Of the entire group of 68 transmediastinal electrodes, 68% had right epicardial lead placement, 18%o had left epicardial placement, and 15% had indeterminate site.
In summary then, 38% of patients receiving a transvenous electrode system experienced failure by 24 months (22% required a new electrode system and 16% required rehospitalization without replacement). In the transmediastinal and transthoracic patients, the overall 24-months failure rates were 16% and 11% (average combined epicardial failure 14%); 7% and 1% respectively required new electrodes, and 9% and 10% required revision of the electrode system. This higher rate of failure for the endocardial method is significantly different (P < .05).
The overall six-month endocardial cumulative failure rate was 26% (15% replacements), while 3% transmediastinal (all replacements) and no transthoracic electrodes had failed by six months. By 12 months, 28% transvenous electrodes had failed (17% replaced), 11% transmediastinal had failed (7% replacements), and 4% transthoracic had failed (all managed without replacement) and, by 18 months, 32% transvenous electrodes had failed ( 19% replaced), 12% transmediastinal had failed (7% replaced) and 7% transthoracic had failed (1% replaced).
Deaths (table 8) Of the 247 total electrode insertions, four patients died during their hospitalization (2%). Three deaths were observed in the 129 transvenous patients (2%), one in the 68 transmediastinal patients (1%), and none in the transthoracic group. Two of the transvenous hospital deaths were not sudden and were secondary to myocardial infarction (six and eight days after insertion). The one transvenous sudden hospital death, early in our experience, occurred six days after insertion and was attributed to inadvertent placement of the electrode catheter into the coronary sinus, resulting in intermittent atrial and ventricular pacing. The one transmediastinal hospital death (9 days postoperatively) was secondary to a massive pulmonary embolus. By six months, 8% of the 247 had died, 12% had died by 12 months, 15% by 18 months, and, at the end of two years, 19% of the original 247 had died. When death records were reviewed, half of all deaths were noted to be sudden and unexplained, and there appeared to be an unusually high cluster of these deaths between six and 12 months (8 of 23 sudden deaths). This prompted a review of those electrode "failures" not related to infection or erosion.
Sudden death occurred in 14 patients with transvenous electrodes and there were 39 instances of electrode failure (unrelated to infection or erosion) by 24 months. Both the sudden deaths and electrode failures, however, were scattered randomly over the two-year period.
In the transmediastinal group, six of the eight instances of sudden death and six of the nine complications of electrode failure occurred between six 
Discussion
It is clear that the three electrode populations were different and not directly comparable. This was not a random study. The transvenous patients were older, with more coronary disease and more associated illnesses, the transthoracic patients younger with little coronary disease and associated illnesses, and the transmediastinal group was intermediate.
In spite of this, the transvenous patients had lower hospital morbidity and a shorter period of hospitalization. As shown in this as well as in the two earlier Duke Hospital series1' 2 (table 9), their major problem was the high incidence of both early and late electrode failure. Two-year complete follow-up seemed to increase the incidence of failure over that reported in the other series presented in table 9. However, despite shorter and more varied periods of follow-up, several groups reported an approximately 30% transvenous failure rate.
The transmediastinal patients had a higher incidence of hospital complications and longer periods of hospitalization. They also had the problem of pacing failure caused by threshold elevation between six and 12 months (all in the right ventricular implants) and high incidence of sudden deaths in this same period (most in right ventricular implants). The numbers of these complications are small and therefore the results are preliminary. If they are confirmed in other series, it would be concluded that the right ventricle is not an acceptable site for implantation of the standard epicardial electrodes.
Transthoracic patients had similar hospital morbidity, length of hospital stay, and 24-month failure rate when compared with the transmediastinal group. However, the incidence of electrode failure requiring replacement and of sudden death was much less than in transmediastinal patients. Notable also is the low hospital mortality in both epicardial groups (0% anid 1%) as compared with other series listed in which it is as high as 10%. hospital morbidity is not strictly comparable in the various listed series because of varying criteria for the definition of complications. Considering the population as a whole, the increased hospital morbidity with epicardial pacing was more than balanced by the inability of a high percentage of transvenous electrodes to function successfully for two years. The often-reported documentation of endocardial electrode instability which has been confirmed by the compulsive follow-up in this study dictates the need for an alternative approach to permanent pacing. Our experience over three series now testifies to the achievability of relatively low epicardial failure rates (3 to 16%) as compared with other reported series (up to 53 and 65%).
Since electrode implantation in this series was not randomly allocated and the groups are not entirely comparable, it is probable that there are subgroups in which the morbidity associated with implantation of epicardial electrodes would outweigh the long term advantages of this method. We attempted therefore to define such subgroups by examining hospital morbidity and mortality in small groups of patients with epicardial leads with age greater than 69, coronary artery disease, congestive heart failure, diabetes mellitus, hypertension or combinations of these. The subgroups were quite small, but we could not find any association between the above characteristics, singly or in combination, and either hospital morbidity or mortality. However, these patients did stay in the hospital slightly longer than the other patients with epicardial electrodes.
This study has demonstrated important differences between transmediastinal and transthoracic electrodes and raises, but does not answer, the critical question of whether an epicardial system involving the right ventricle can be an acceptable alternative to transvenous pacing. Ideally, any limited approach to epicardial pacing would minimize postoperative moribidity but allow permanently effective ventricular electrode implantation. Although historically the transmediastinal approach was designed to avert thoracotomy,'2 the pleural space has frequently been entered, pulmonary complications have not been significantly changed and, although periods of hospitalization have been slightly shorter as compared with standard anterolateral thoracotomy, the difference is not significant. Both this failure of the transmediastinal approach to significantly alter postoperative morbidity and the incidence of threshold elevation remote from right Circulation, Volume XLIX, March 1974 ventricular implantation suggest that limitation of the thoracotomy should not take precedence over left ventricular implantation. The perspective obtained from evaluation of a long and homogeneous follow-up period in patients with all three methods of electrode implantation has altered the conclusions in this study from those of previous studies from this institution.1' 2, 13 These had been optimistic that either the relatively less invasive transvenous or transmediastinal approaches would permit stable long-term pacing without the immediate morbidity of the transthoracic approach. Pending analysis of larger, more homogeneous subgroups of patients or development of alternative systems of electrode fixation, we would select an epicardial approach with implantation of left ventricular electrodes unless factors prohibitive to general anesthesia and thoracotomy exist in the individual patient.
